Pharma Research

An International Peer Reviewed, Indexed Journal
Call Us


Send us mail




The Pharma Research Journal

The Pharma Research (TPR) is a peer-reviewed multi-disciplinary pharmaceutical Journal, published half yearly and help in information exchange within the pharmaceutical arena. Specific scientific topics of interest to the journal include, but are not limited to: pharmaceutics, industrial pharmacy, pharmacognosy, toxicology, medicinal chemistry, novel analytical methods, computational and modeling approaches to drug design, bio-medical experience, clinical investigation, rational drug prescribing, pharmacoeconomics, biotechnology, nanotechnology, biopharmaceutics, Adverse drug monitoring, pharmacovigilance, pharmacotherapeutics, pharmacodynamics and physical pharmacy.

Date Of Issue

The journal will be issued on 15th of June and December every year. A competing interest exists when professional judgment concerning a primary interest may be influenced by a secondary interest. It may arise for the authors of an article in journal when they have a financial interest that may influence, probably without their knowing, their interpretation of their results or those of others. A declaration of interests for all authors must be received before an article can be reviewed and accepted for publication. It should take one of two forms, depending on what type of article you are submitting.

Legal Requirements

The author(s) guarantee(s) that the manuscript will not be published elsewhere in any language without the consent of journal, that the rights of third parties will not be violated, and that the publisher will not be held legally responsible should there be any claims for compensation. Authors wishing to include figures or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.

Pharma Research - 2009-2022